GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone

Clinical trial NCT00763815 · COMPLETED

Trial details

NCT number: NCT00763815
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2008-09-01
Primary completion: 2011-06-01
Enrollment: 484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.